A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting...
influenza vaccine
WHO has released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of...
NIAID-Supported Phase 1 Trial of Potential Broadly Protective Vaccine An early-stage clinical trial testing the safety and immune-stimulating ability of...
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus...
